Table 1.

Patient characteristics of 16 patients with 119 brain metastases

Case no.	Age (years)	KPS at first GKS	Number of brain metastases at first GKS	Total volume of brain metastases at first GKS (cm3)	Symptoms	Pathologic diagnosis	Interval to brain metastases (months)	Other metastases	Survival following diagnosis of brain metastases (months)
1	51	80	2	8.5	Nonea	CCT	43	Liver, bone, AG	17
2	58	70	18	19.5	EW	NA	16	Lung	6
3	50	50	5	14.2	Seizure	ST	27	Lung, liver, bone	8
4	47	70	1	7.5	Nonea	ST	28	NA	11
5	38	100	2	2.3	EWb	NA	84	Colon, SL	13
6	58	50	4	22.5	Seizure	NA	34	NA	14
7	48	60	8	25.2	Aphasia	CCT	9	Lung	5
8	54	100	1	1.4	Nonea	NA	15	Lung, liver	16
9	73	90	2	1.6	EW	NA	15	Colon, spleen	31
10	41	100	1	9.9	Nonea	NA	42	None	34
11	71	80	13	13.6	Headache	CS	40	NA	6
12	61	100	1	9.5	EW	CS	25	NA	24
13	63	60	1	8.5	Dysarthria	NA	23	Colon, spleen, pancreas	12
14	52	60	3	5.8	EW	NA	72	Lung	4
15	67	80	4	42.6	Dizziness	ST	36	NA	11
16	46	100	1	0.6	Nonea	ST	0	SL	17

EW extremity weakness, AG adrenal gland, SL supraclavicular lymph node, NA not acquired, CCT clear cell tumor, ST serous tumor, CS carcinosarcoma

^aBrain metastasis detected after MRI and/or CT

^bTransient EW